FSAGX | RYMPX | FSAGX / RYMPX | |
Total Expense Ratio | 0.68 | 1.55 | 44% |
Annual Report Gross Expense Ratio | 0.68 | 1.58 | 43% |
Fund Existence | 39 years | 22 years | - |
Gain YTD | 49.715 | 39.571 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.24B | 104M | 2,151% |
Annual Yield % from dividends | 2.35 | 0.00 | - |
Returns for 1 year | 52.79 | 33.65 | 157% |
Returns for 3 years | 54.80 | 39.82 | 138% |
Returns for 5 years | 39.17 | 33.66 | 116% |
Returns for 10 years | 129.73 | 97.64 | 133% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RBAIX | 26.69 | 0.05 | +0.19% |
T. Rowe Price Balanced I | |||
EEMEX | 8.41 | 0.01 | +0.12% |
MFS Emerging Markets Equity Research R2 | |||
QLSGX | 25.80 | -0.03 | -0.12% |
Federated Hermes MDT Small Cap Growth R6 | |||
TMITX | 10.07 | -0.04 | -0.40% |
Transamerica Mid Cap Growth I3 | |||
FDCGX | 82.25 | -0.52 | -0.63% |
Fidelity Advisor Consumer Staples C |